AVDL - AVADEL PHARMACEUTICALS PLC

QQQ $ 601.76 $ 0.00 (0 %)

DIA $ 464.92 $ 0.00 (0 %)

SPY $ 663.77 $ 0.00 (0 %)

TLT $ 89.38 $ 0.00 (0 %)

GLD $ 371.79 $ 0.00 (0 %)

Previous Close

$ 23.02

Open

$ 23.25

Bid

$ 22.56 x 9

Ask

$ 23.86 x 2

Day's Range

-- - --

52 Week Range

$ 6.38 - $ 23.57

Volume

4,023,192

Average Volume

Market Cap

2.25B

Beta (5Y Monthly)

$ 1.25

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	11-04-2025	09-30-2025	10-Q
2	08-07-2025	06-30-2025	10-Q
3	05-07-2025	03-31-2025	10-Q
4	03-03-2025	01-01-1970	10-K
5	11-12-2024	09-30-2024	10-Q
6	08-08-2024	06-30-2024	10-Q
7	05-08-2024	03-31-2024	10-Q
8	02-29-2024	12-31-2023	10-K
9	11-08-2023	09-30-2023	10-Q
10	08-09-2023	06-30-2023	10-Q
11	05-04-2023	03-31-2023	10-Q
12	03-29-2023	12-31-2022	10-K
13	11-09-2022	09-30-2022	10-Q
14	08-09-2022	06-30-2022	10-Q
15	05-09-2022	03-31-2022	10-Q
16	03-16-2022	12-31-2021	10-K
17	11-08-2021	09-30-2021	10-Q
18	08-09-2021	06-30-2021	10-Q
19	05-10-2021	03-31-2021	10-Q
20	03-09-2021	12-31-2020	10-K
21	11-09-2020	09-30-2020	10-Q
22	08-10-2020	06-30-2020	10-Q
23	05-11-2020	03-31-2020	10-Q
24	03-16-2020	12-31-2019	10-K
25	11-12-2019	09-30-2019	10-Q
26	08-09-2019	06-30-2019	10-Q
27	05-08-2019	03-31-2019	10-Q
28	03-15-2019	12-31-2018	10-K
29	11-05-2018	09-30-2018	10-Q
30	08-07-2018	06-30-2018	10-Q
31	05-04-2018	03-31-2018	10-Q
32	03-16-2018	12-31-2017	10-K
33	11-09-2017	09-30-2017	10-Q
34	08-09-2017	06-30-2017	10-Q
35	05-10-2017	03-31-2017	10-Q
36	03-28-2017	12-31-2016	10-K
37	11-14-2016	09-30-2016	10-Q
38	08-15-2016	06-30-2016	10-Q
39	05-10-2016	03-31-2016	10-Q
40	03-15-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

top-2-health-care-stocks-that-may-fall-off-a-cliff-this-month

Top 2 Health Care Stocks That May Fall Off...
11/17/2025 13:15:43

Avadel Pharmaceuticals' Board Of Directors...
11/17/2025 10:47:42

Lundbeck Proposal Values Avadel at up to $23.00 per Ordinary Share, a Total of Approximately $2.4 billionPursuant to Alkermes T...

lundbecks-higher-buyout-proposal-challenges-alkermes-pending-2-billion-avadel-deal

Lundbeck's Higher Buyout Proposal Challeng...
11/14/2025 16:37:57

Avadel reviews Lundbeck's unsolicited $23 offer while maintaining its agreement with Alkermes as its board evaluates whethe...

legence-cidara-therapeutics-avadel-pharmaceuticals-omeros-and-other-big-stocks-moving-higher-on-friday

Legence, Cidara Therapeutics, Avadel Pharm...
11/14/2025 14:54:48

Alkermes Says It Is Considering Options Af...
11/14/2025 12:47:54

12-health-care-stocks-moving-in-fridays-pre-market-session

12 Health Care Stocks Moving In Friday's P...
11/14/2025 12:06:17

Avadel Board Says Lundbeck Proposal May Be...
11/14/2025 10:51:53

Avadel Receives Unsolicited Lundbeck Propo...
11/14/2025 10:51:23

Wells Fargo Maintains Equal-Weight on Avad...
11/07/2025 18:48:38

Wells Fargo analyst Benjamin Burnett maintains Avadel Pharmaceuticals (NASDAQ:AVDL) with a Equal-Weight and raises the price...

Avadel Pharmaceuticals Q3 EPS $0.00 Misses...
11/04/2025 21:37:47

Avadel Pharmaceuticals (NASDAQ:AVDL) reported quarterly earnings of $0.00 per share which missed the analyst consensus estimate...

UBS Downgrades Avadel Pharmaceuticals to N...
10/28/2025 11:51:44

UBS analyst Ashwani Verma downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Buy to Neutral and maintains the price target...

deal-dispatch-from-four-roses-bourbon-to-quantum-stakes-here-are-this-weeks-sector-shake-ups

Deal Dispatch: From Four Roses Bourbon To ...
10/24/2025 16:20:19

Four Roses, Six Flags, and Trump's potential Quantum investments: This week's deal activity involves big bets across va...

Leerink Partners Downgrades Avadel Pharmac...
10/23/2025 21:52:33

Leerink Partners analyst Marc Goodman downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Outperform to Market Perform and ...

Tesla To Rally More Than 16%? Here Are 10 ...
10/23/2025 12:48:03

this-winnebago-industries-analyst-is-no-longer-bullish-here-are-top-5-downgrades-for-thursday

This Winnebago Industries Analyst Is No Lo...
10/23/2025 12:32:36

HC Wainwright & Co. Downgrades Avadel Phar...
10/23/2025 11:59:05

HC Wainwright & Co. analyst Raghuram Selvaraju downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Buy to Neutral and l...

alkermes-strikes-21-billion-avadel-deal-gains-access-to-narcolepsy-drug-lumryz

Alkermes Strikes $2.1 Billion Avadel Deal,...
10/22/2025 19:18:55

Alkermes agrees to acquire Avadel for $2.1 billion, adding the successful Lumryz drug and accelerating entry into sleep medicin...

Beyond The Numbers: 5 Analysts Discuss Ava...
10/22/2025 18:00:44

Jefferies Downgrades Avadel Pharmaceutical...
10/22/2025 16:07:34

Jefferies analyst Andrew Tsai downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Buy to Hold and lowers the price target f...

Needham Downgrades Avadel Pharmaceuticals ...
10/22/2025 14:37:20

Needham analyst Ami Fadia downgrades Avadel Pharmaceuticals (NASDAQ:AVDL) from Buy to Hold.